Using the iconPCR system, n6 presents enhancements in low-pass whole genome sequencing. This approach enables balanced, ...

Ultima Genomics has transformed highly efficient, production-scale sequencing while reducing the sequencing cost per genome ...

St. Jude researchers advance CASTs, enhancing precision and activity for next-generation genome-editing therapies.

Aurigene Oncology Limited, a clinical-stage biopharmaceutical company developing novel therapies in oncology, today announced ...

Reviewers viewed the targeting of TFAM as innovative and the study's conclusions as potentially important (especially the effects on inflammation). However, the lack of evidence for a direct effect of ...

The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...

Researchers at a Harvard Medical School laboratory are uncertain how they will continue supporting a large public genetic database after its primary source of funding expired last month.

Boston researchers sequenced a full human genome in record time, under four hours. The advance could speed life-saving diagnoses for newborns in intensive care. Boston Children’s Hospital, in ...

The field of neurogenetic and neurodevelopmental disorders has seen significant advancements in recent years, yet the ...